Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Biora Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −2 vs. Q4 2023
- Shares held
- 12.1M
- +150.3K (+1.3%) vs. Q4 2023
- Total value
- $13.3M
- −$2.81M (−17.5%) vs. Q4 2023
- New holders
- 5
- 7 more added
- Sold out
- 7
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 21 | $6.13M |
| Q2 2024 | 29 | $8.07M |
| Q1 2024 | 28 | $13.3M |
| Q4 2023 | 30 | $16.1M |
| Q3 2023 | 25 | $25.9M |
| Q2 2023 | 31 | $13.2M |
| Q1 2023 | 32 | $6.46M |
| Q4 2022 | 48 | $8.68M |
| Q3 2022 | 47 | $24.1M |
| Q2 2022 | 49 | $34.5M |
| Q1 2022 | 55 | $59.2M |
| Q4 2021 | 57 | $101.3M |
| Q3 2021 | 36 | $72.8M |
| Q2 2021 | 42 | $196.5M |
| Q1 2021 | 48 | $205.6M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Biora Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Athyrium Capital Management, LP | 10,929,762 | $12.0M | 16.52% | 00.0% | Unchanged |
| Vanguard Group Inc | 576,030 | $633.6K | 0.00% | +68,095+13.4% | Added |
| Geode Capital Management, LLC | 199,245 | $219.2K | 0.00% | +106,207+114.2% | Added |
| Northern Trust Corp | 68,616 | $75.5K | 0.00% | +53,055+340.9% | Added |
| BlackRock Inc. | 65,051 | $71.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 33,073 | $36.4K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 29,200 | $32.1K | 0.00% | −9,500−24.5% | Reduced |
| Bridgeway Capital Management, LLC | 26,504 | $29.2K | 0.00% | −10,776−28.9% | Reduced |
| LPL Financial LLC | 21,110 | $23.2K | 0.00% | +394+1.9% | Added |
| Jane Street Group, LLC | 17,778 | $19.6K | 0.00% | +17,778 | New |
| Leonard Rickey Investment Advisors P.L.L.C. | 16,362 | $18.0K | 0.00% | +16,362 | New |
| CIBC Asset Management Inc | 15,110 | $16.6K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11,786 | $13.0K | 0.00% | +3,630+44.5% | Added |
| Virtu Financial LLC | 11,009 | $12.0K | 0.00% | −8,754−44.3% | Reduced |
| Millennium Management LLC | 10,890 | $12.0K | 0.00% | −14,881−57.7% | Reduced |
| Tower Research Capital LLC (TRC) | 7,219 | $7.94K | 0.00% | −10−0.1% | Reduced |
| Barclays PLC | 5,797 | $6.38K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,448 | $5.99K | 0.00% | +628+13.0% | Added |
| TD Waterhouse Canada Inc. | 1,120 | $830 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 647 | $711 | 0.00% | 00.0% | Unchanged |
| Riggs Asset Managment Co. Inc. | 400 | $440 | 0.00% | +100+33.3% | Added |
| Clearstead Advisors, LLC | 144 | $107 | 0.00% | +144 | New |
| Steward Partners Investment Advisory, LLC | 32 | $35 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 17 | $18 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 5 | $4 | 0.00% | 00.0% | Unchanged |
| Tucker Asset Management LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 78 | $0 | 0.00% | +78 | New |
| CWM, LLC | 8 | $0 | 0.00% | +8 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −50,849−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −15,085−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,146−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −14−100.0% | Sold out |